Under construction – not a live service
Sign in
Not yet recruitingNo phase

Prospective AI-SC Trial

Key facts

Who runs it
University Health Network, Toronto
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
200 people, planned
Started
13 Nov 2026
Expected to end
Nov 2028
Type of study
Observational
Treatments tested
  • Artificial Intelligence Selection Committee (AI-SC)
Record updated
10 November 2026

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 2 criteriaShow less

Who can take part

  • age 18 years or older; undergoing liver transplant assessment at UHN; anticipated discussion at the UHN liver transplant selection committee; ability to provide informed consent

Who cannot take part

  • refusal or withdrawal of consent; cases for which required committee presentation information is unavailable to the study team; cases in which urgent clinical circumstances do not allow the consent process to occur before committee review; cases in which the treating team determines that research contact is inappropriate because of clinical, emotional, or logistical circumstances; Refusal to participate will not affect transplant assessment, committee review, clinical management, waitlist eligibility, or access to future care

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This is a prospective, pre-post implementation study designed to evaluate how artificial intelligence-based selection committee (AI-SC) recommendations affect decision-making when integrated into routine clinical workflows. The study will focus on individual liver transplant candidacy decisions as the primary unit of analysis. Researchers will observe and analyze these decisions during weekly University Health Network (UHN) Liver Transplant Selection Committee meetings over an approximate 12-month period. The goal is to determine if the deployment of AI-SC recommendations changes, optimizes, or influences the committee's final transplant candidacy determinations compared to baseline practices.

Treatments tested

  • Artificial Intelligence Selection Committee (AI-SC)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Artificial Intelligence-Selection Committee (AI-SC) Trial: A Prospective Study of Human-AI Collaborative Decision-Making in Liver Transplant Selection
Fit questions
Built from NCT07927153, who can take part
Record updated
10 November 2026